Please try another search
Imunon, Inc. is a clinical-stage biotechnology company. It is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases. It has two platform technologies: TheraPlas platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies, and the PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. Its lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer. IMNN-001 works by instructing the body to produce cancer fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site. Additionally, it is conducting preclinical studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus to validate its PLACCINE platform. Its platform technologies are based on the delivery of nucleic acids with synthetic delivery systems that are independent of viral vectors or devices.
Name | Age | Since | Title |
---|---|---|---|
Michael H. Tardugno | 71 | 2007 | Executive Chairman |
Donald P. Braun | 74 | 2015 | Independent Director |
Wafik El-Deiry | - | - | Member of Advisory Board |
Frederick J. Fritz | 73 | 2011 | Independent Director |
Mark W. Dewhirst | - | - | Member of Advisory Board |
Michael E. Weinblatt | - | - | Member of Advisory Board |
David Cheresh | - | - | Member of Advisory Board |
Jerry Glickson | - | - | Member of Advisory Board |
Britt A. Glaunsinger | - | 2021 | Member of the Advisory Board |
Luke D. Handke | - | 2021 | Member of Vaccine Advisory Board |
Patrick Ott | - | 2023 | Member of Scientific Advisory Board |
Peter Corry | - | - | Member of Advisory Board |
Stacy R. Lindborg | 54 | 2021 | Independent Director |
Xinzhen Yang | - | 2021 | Member of the Advisory Board |
Christine A. Pellizzari | 56 | 2021 | Independent Director |
Dan H. Barouch | - | 2021 | Member of Vaccine Advisory Board |
Sachet A. Shukla | - | 2023 | Member of Scientific Advisory Board |
James E. Dentzer | 57 | 2022 | Independent Director |
John W. Shiver | - | - | Member of Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review